400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / EGFR / Theliatinib/西利替尼
CAS No.: 1353644-70-8
Synonyms: Xiliertinib;HMPL-309;xiliertinibum
Theliatinib, is a small molecule, epidermal growth factor receptor tyrosine kinase inhibitor with potential antineoplastic and anti-angiogenesis activities.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02601274 | Cancer | Phase 1 | Recruiting | March 2019 | China, Beijing ... more >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Lin Shen, PHD lin100@medmail.com.cn China, Guangdong Sun-Yat-sen univercity cancer centre Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhang li, PhD Collapse << |
NCT02601248 | Cancer | Phase 1 | Completed | - | China ... more >> Tianjin Cancer Hospital Tianjin, China, 300060 Collapse << |
实验方案
技术信息
CAS号 | 1353644-70-8 | 储存条件 |
|
|
分子式 | C25H26N6O2 | 运输 | 蓝冰 | |
分子量 | 442.51 | 别名 | Xiliertinib;HMPL-309;xiliertinibum;西利替尼 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02601274 | Cancer | Phase 1 | Recruiting | March 2019 | China, Beijing ... more >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Lin Shen, PHD lin100@medmail.com.cn China, Guangdong Sun-Yat-sen univercity cancer centre Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhang li, PhD Collapse << |
NCT02601248 | Cancer | Phase 1 | Completed | - | China ... more >> Tianjin Cancer Hospital Tianjin, China, 300060 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网